British Pharmacopoeia 2001 PDF Download

Author: Great Britain. Medicines Commission
Publisher:
ISBN: 9780113224463
Category : Medical
Languages : en
Pages : 1612

View

Book Description
The Pharmacopoeia is published by the Department of Health on behalf of the Medicines Control Agency. The MCA is the body responsible for creating the standards for medicinal products and the control and licensing of medicines for use in the UK. The 4-volume work, CD-ROM, and web site contain 2,760 monographs for substances and articles used in the practice of medicine, including all the monographs from the updated third edition of the European pharmacopoeia. It provides all the current UK pharmacopoeial standards for medicines for human use.

Author: Anthony C. Cartwright
Publisher: Routledge
ISBN: 1317039793
Category : History
Languages : en
Pages : 266

View

Book Description
The British Pharmacopoeia has provided official standards for the quality of substances, medicinal products and articles used in medicine since its first publication in 1864. It is used in over 100 countries and remains an essential global reference in pharmaceutical research and development and quality control. This book explores how these standards have been achieved through a comprehensive review of the history and development of the pharmacopoeias in the UK, from the early London, Edinburgh and Dublin national pharmacopoeias to the creation of the British Pharmacopoeia and its evolution over 150 years. Trade in medicinal substances and products has always been global, and the British Pharmacopoeia is placed in its global context as an instrument of the British Empire as it first sought to cover the needs of countries such as India and latterly as part of its role in international harmonisation of standards in Europe and elsewhere. The changing contents of the pharmacopoeias over this period reflect the changes in medical practice and the development of dosage forms from products dispensed by pharmacists to commercially manufactured products, from tinctures to the latest monoclonal antibody products. The book will be of equal value to historians of medicine and pharmacy as to practitioners of medicine, pharmacy and pharmaceutical analytical chemistry.

Author:
Publisher: Stationery Office Books (TSO)
ISBN: 9780113229321
Category : Reference
Languages : en
Pages : 0

View

Book Description
The British Pharmacopoeia (BP) 2013 is the authoritative, current collection of standards for UK medicinal substances and the official source of all UK pharmaceutical quality standards. It is an essential reference for anyone involved in pharmaceutical research, development, manufacture and testing, and plays a vital role in ensuring that all medicinal substances on the UK market meet standards of safety, quality and efficacy. The BP comprises monographs, which set out the mandatory standards for active substances, excipients and formulated preparations, together with supporting General Notices, Appendices (test methods, reagents, etc) and Reference Spectra. Detailed information and guidance on various aspects of current pharmacopoeial policy and practice are provided in the Supplementary Chapters of the BP. The BP is supplied in a variety of formats designed for ease of use and a wide range of applications. The hard copy edition package comprises a boxed six volume set containing BP in five volumes and the BP (Veterinary) volume, plus single user access to the CD-ROM and BP Online via www.pharmacopoeia.co.uk, the dedicated BP website. The online format is easy to network, allowing access for a specified number of users or across an entire organisation site.

Author: Anthony C. Cartwright
Publisher: Routledge
ISBN: 1317039785
Category : History
Languages : en
Pages : 281

View

Book Description
The British Pharmacopoeia has provided official standards for the quality of substances, medicinal products and articles used in medicine since its first publication in 1864. It is used in over 100 countries and remains an essential global reference in pharmaceutical research and development and quality control. This book explores how these standards have been achieved through a comprehensive review of the history and development of the pharmacopoeias in the UK, from the early London, Edinburgh and Dublin national pharmacopoeias to the creation of the British Pharmacopoeia and its evolution over 150 years. Trade in medicinal substances and products has always been global, and the British Pharmacopoeia is placed in its global context as an instrument of the British Empire as it first sought to cover the needs of countries such as India and latterly as part of its role in international harmonisation of standards in Europe and elsewhere. The changing contents of the pharmacopoeias over this period reflect the changes in medical practice and the development of dosage forms from products dispensed by pharmacists to commercially manufactured products, from tinctures to the latest monoclonal antibody products. The book will be of equal value to historians of medicine and pharmacy as to practitioners of medicine, pharmacy and pharmaceutical analytical chemistry.

Author: British Pharmacopoeia Commission
Publisher:
ISBN: 9780113230846
Category :
Languages : en
Pages :

View

Book Description
Updated annually, the British Pharmacopoeia (BP) is the only comprehensive collection of authoritative official standards for UK pharmaceutical substances and medicinal products. It includes approximately 4,000 monographs which are legally enforced by the Human Medicines Regulations 2012. Where a BP monograph exists, medicinal products or active pharmaceutical ingredients sold or supplied in the UK must comply with the relevant monograph.All monographs and requirements of the European Pharmacopoeia (Ph. Eur.) are reproduced in the BP, making the BP a convenient and fully comprehensive set of standards that can be used across Europe and beyond.

Author: British Pharmacopoeia Commission
Publisher:
ISBN: 9780113225958
Category : Medical
Languages : en
Pages : 736

View

Book Description
This three volume collection with CD-ROM contains the authoritative standard reference for medicines in the United Kingdom. It provides information on the quality of substances used throughout medicine and pharmaceutics. Two volumes contain the Pharmacopoeia while a third volume presents British Pharmacopoeia (Veterinary).

Author: British Pharmacopoeia Commission
Publisher:
ISBN: 9780113230716
Category :
Languages : en
Pages :

View

Book Description
Updated annually, the BP is the official, authoritative collection of standards for UK medicinal substances for human and veterinary use. The BP 2015 includes almost 3,500 monographs. All monographs and requirements of the European Pharmacopoeia are also reproduced in the BP, making it an essential reference for students, lecturers and researchers. The online product provides subscribers with access to the British pharmacopoeia 2019, British pharmacopoeia (veterinary) 2019 and the current edition and supplements of Britsh approved names. Concurrent access to the 2014 onwards is also available

Author: Stationery Office
Publisher:
ISBN: 9780115006951
Category :
Languages : en
Pages : 740

View

Book Description

Author: Tom Reynolds
Publisher: CRC Press
ISBN: 0203476344
Category : Health & Fitness
Languages : en
Pages : 414

View

Book Description
Aloes are a large genus of plants, about 450 species, from sub-Saharan Africa, Madagascar, and parts of Arabia. Many species are widespread in warm or tropical semi-arid regions, yet the distribution of others is limited to a few living in desert or wet mountainous regions. While some species have been adopted as medicinal plants since ancient time

Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309269393
Category : Medical
Languages : en
Pages : 377

View

Book Description
The adulteration and fraudulent manufacture of medicines is an old problem, vastly aggravated by modern manufacturing and trade. In the last decade, impotent antimicrobial drugs have compromised the treatment of many deadly diseases in poor countries. More recently, negligent production at a Massachusetts compounding pharmacy sickened hundreds of Americans. While the national drugs regulatory authority (hereafter, the regulatory authority) is responsible for the safety of a country's drug supply, no single country can entirely guarantee this today. The once common use of the term counterfeit to describe any drug that is not what it claims to be is at the heart of the argument. In a narrow, legal sense a counterfeit drug is one that infringes on a registered trademark. The lay meaning is much broader, including any drug made with intentional deceit. Some generic drug companies and civil society groups object to calling bad medicines counterfeit, seeing it as the deliberate conflation of public health and intellectual property concerns. Countering the Problem of Falsified and Substandard Drugs accepts the narrow meaning of counterfeit, and, because the nuances of trademark infringement must be dealt with by courts, case by case, the report does not discuss the problem of counterfeit medicines.